Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature

Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature

Historically, secondary amyloidosis has been a feared complication of chronic inflammatory conditions. The fibril protein AA derives from the acute phase reactant serum amyloid A (SAA). Long-term elevation of SAA levels remains a major risk factor for the development of AA amyloidosis in rheumatic d...

Full description

Bibliographic Details
Main Authors: Per Eriksson, Johan Mölne, Lina Wirestam, Christopher Sjöwall
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Medicine
Subjects:
amyloidosis—diagnosis
ankylosing spondylitis
interleukin-6
nephropathy
proteinuria—nephrotic syndrome
tocilizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.661101/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.661101/full

Similar Items